Clinical Trial Update: Intrahepatic Reinfusion of CD133+ Stem Cells in Cirrhotic Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intrahepatic reinfusion of CD133+ stem cells in patients with liver cirrhosis; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• CD133+ stem cell infusion

Snippet

Sponsor: University of Bologna | Conditions: Liver Cirrhosis | Phase 1 | Status: UNKNOWN